Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AIM ImmunoTech initiates dosing in intranasal Covid-19 drug study

pharmaceutical-technologyMarch 10, 2021

Tag: AIM ImmunoTech , COVID-19 , CHDR , Ampligen

PharmaSources Customer Service